India orders new drug-making standards after overseas deaths

The Indian government has issued a notification requiring pharmaceutical companies to adhere to new manufacturing standards in response to concerns over the quality and safety of drugs. The move comes in the wake of overseas deaths linked to Indian-made drugs since 2022, prompting increased scrutiny of the $50 billion pharmaceutical industry.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/oEs7zBS
via IFTTT